Delaware

  • April 28, 2026

    Duracell Loses Bid To Ax BASF's Lithium Battery Secrets Suit

    Battery-maker Duracell cannot escape chemical company BASF Corp.'s lawsuit accusing it of stealing trade secrets about its lithium battery technology after gaining access to the information through a cooperation agreement, a Delaware federal judge ruled Tuesday.

  • April 28, 2026

    Judge Grants Mortgage Broker Stock Sale Notice

    A Delaware bankruptcy judge on Tuesday allowed bankrupt home lending broker Impac Mortgage to continue to control the sale of its stock after hearing that millions of dollars in transactions took place despite an emergency order he entered Monday to restrict trading.

  • April 28, 2026

    Uber, Drivers Drop Appeal In Yearslong Misclassification Fight

    A group of Uber Black drivers and the ride-hailing company agreed Tuesday to dismiss the drivers' appeal before the Third Circuit in a protracted worker classification dispute that has spanned a decade, according to a federal court filing.

  • April 28, 2026

    Ex-Exec, Korean Chip Co. Clash Over $2.36M Buyback

    A Korean semiconductor company specializing in memory chips clashed with a former executive in Delaware Chancery Court on Tuesday over whether a $2.36 million stock buyback stripped him of the right to sue before he filed a records request action.

  • April 28, 2026

    Flipcause Converted To Chapter 7 After Sale, Creditor Deal

    A Delaware judge Tuesday agreed to convert the bankruptcy of charity financial technology group Flipcause to a Chapter 7 liquidation after its Chapter 11 trustee sold its assets and reached a settlement with creditors.

  • April 28, 2026

    Hikma, Cipla Cut Deals In Pfizer Heart Drug Patent Case

    Hikma Pharmaceuticals PLC and Cipla Ltd. have reached settlements with Pfizer Inc. in a case over the two defendants' efforts to create generic versions of the heart medication Vyndamax.

  • April 28, 2026

    Meet The Attys Arguing The High Court 'Skinny Label' Case

    When the U.S. Supreme Court hears arguments Wednesday in a patent case involving "skinny labels" on generic drugs, a longtime patent attorney as well as a government attorney who often handles intellectual property cases will face an appellate specialist who has argued many high court cases.

  • April 28, 2026

    NJ Man Asks 3rd Circ. To Revisit $40M Tax Conviction

    A New Jersey man convicted of making $40 million from filing false tax returns in a countrywide securities scheme asked the Third Circuit to reconsider affirming his conviction, citing what he described as a conflict of interest and a misreading of arguments in the ruling against him.

  • April 28, 2026

    $20M Hair Business Sale Dispute Hits Chancery Court

    A medical aesthetics technology company has sued a Korean buyer in the Delaware Chancery Court, accusing it of backing out of a $20 million deal to purchase a hair restoration business after attempting to slash the price at the last minute.

  • April 27, 2026

    Meta Seeks A Rally As Instagram Addiction Suit Losses Mount

    After a run of litigation losses, Meta Platforms Inc. will have to rethink its strategy in and out of court in an effort to beat back suits from coast to coast claiming that it is illegally hooking kids on Instagram, experts said, with everything from aggressive litigation to a global settlement on the table.

  • April 27, 2026

    Canada Provinces Back Hockey League's Antitrust Dismissal

    The governments of four Canadian provinces have urged the Ninth Circuit to reject an appeal from junior hockey players accusing the National Hockey League and its developmental organizations of suppressing compensation.

  • April 27, 2026

    Trump SPAC, Ex-CEO Clash Over $2M In Fees

    A Delaware Chancery Court hearing Monday laid bare a procedural fight over whether a Trump-linked SPAC must immediately pay disputed legal fees to its former CEO or can withhold them while seeking review of a magistrate's ruling.

  • April 27, 2026

    Moderna Hit With Suit Over CureVac COVID Patents

    BioNTech subsidiary CureVac has launched a new patent infringement suit against Moderna, claiming its COVID-19 vaccine infringed a handful of patents, saying the Massachusetts-based company "exploited" its messenger RNA technology.

  • April 27, 2026

    Kitchen Design Co. Abruptly Hits Ch. 7 With $100M+ Liabilities

    Wren US Holdings Inc., a kitchen design firm based in the northeastern United States, has filed for Chapter 7 liquidation in Delaware, citing between $100 million and $500 million each of assets and liabilities.

  • April 27, 2026

    3rd Circ. Panel Once Again Backs Talc Co. Whittaker's Ch. 11

    The Third Circuit on Monday upheld its decision that Whittaker Clark & Daniels was authorized to file for Chapter 11 and certain claims against the defunct talc supplier's corporate successor belong to the debtor, not personal injury claimants.

  • April 27, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week tackled a fresh mix of deal litigation, procedural disputes and fiduciary duty claims, with several rulings and filings underscoring the court's continued focus on contractual precision, forum enforcement and the limits of stockholder challenges.

  • April 24, 2026

    Up Last At High Court: TPS, Geofence, Skinny Labels

    The U.S. Supreme Court will close out its oral argument portion of the 2025 October term by hearing a panoply of disputes over the constitutionality of geofence warrants, the existence of aiding and abetting torture claims, and the rescission of temporary protected status for hundreds of thousands of immigrants.

  • April 24, 2026

    Natera Tells Justices CareDx Made Up Circ. Split In Petition

    Natera asked the U.S. Supreme Court to reject a petition from rival CareDx asking it to review a Third Circuit decision that erased a $45 million jury verdict stemming from CareDx's false advertising claims, saying Friday the circuit split that CareDx claims exists is "imagined."

  • April 24, 2026

    States Seek Early Win In Challenge To Trump Mail-In Ballot EO

    A coalition of Democrat-led states is asking a Massachusetts federal judge to permanently block core provisions of President Donald Trump's executive order limiting mail-in voting, arguing the directive unlawfully encroaches on states' authority over elections and violates the Constitution's separation of powers.

  • April 24, 2026

    One Certainty As Tariff Refunds Start: 'There Will Be Litigation'

    The launch of the refund process for tariffs struck down by the U.S. Supreme Court marks the start of lengthy and multifaceted court battles as companies fight with consumers — and amongst themselves — about who gets a slice of the $166 billion pie, experts told Law360.

  • April 24, 2026

    GPGI Faces Suit Over Nevada Reincorporation

    A GPGI Inc. investor has filed suit in Delaware seeking to challenge the company's planned move to Nevada, saying the reincorporation — part of a wider trend of companies weighing exits from Delaware — would benefit insiders while limiting stockholders' ability to pursue claims tied to earlier transactions.

  • April 24, 2026

    Danaher Execs Face Investor Suit Over Post-COVID Outlook

    Danaher Corp. executives are facing a proposed securities class action in Delaware federal court alleging they profited while misleading stockholders about the slowing sales of its diagnostics and bioprocessing products.

  • April 24, 2026

    Pfizer, Dexcel Drop Heart Drug Case Before Bench Trial

    Pfizer and Israeli generic-drug maker Dexcel on Friday agreed to drop a case Pfizer brought to block Dexcel from creating a generic version of the heart medication Vyndamax.

  • April 24, 2026

    Biotechs Clash Over Cancer Drug Discovery In Chancery

    AnaptysBio and Tesaro, alongside Tesaro parent GlaxoSmithKline LLC, sparred Friday in the Delaware Chancery Court over the scope of discovery in the biotechnology firms' contract fight regarding cancer drug Jemperli, with each side accusing the other of trying to tilt the evidentiary record ahead of a fast-approaching trial in July.

  • April 23, 2026

    GOP-Led States Back Trump In Dem AGs' Mail-In Ballot Suit

    A group of 12 Republican-led states have asked a Massachusetts federal judge to let them intervene as defendants in 23 Democratic-led states' lawsuit over President Donald Trump's March 31 executive order placing limits on mail-in voting.

Expert Analysis

  • Opinion

    3rd Circ. Must Reject EEOC's Flawed Equal Pay Theory

    Author Photo

    To avoid illogical outcomes, the Third Circuit, in Cartee-Haring and Marinello v. Central Bucks School District, should refute the U.S. Equal Employment Opportunity Commission’s recently filed amicus brief in support of the plaintiffs’ bias claims based on pay compared with one single co-worker, say Allan King at Littler and Stephen Bronars at Edgeworth Economics.

  • The Benefits Of Choosing A Niche Practice In The AI Age

    Author Photo

    As artificial intelligence becomes increasingly accessible, lawyers with a niche practice may stand out as clients seek specialized judgment that automation cannot replicate, but it is important to choose a niche that is durable, engaging and a good personal fit, says Daniel Borneman at Lowenstein Sandler.

  • Risk Disclosure Lessons For AI Cos. From Dot-Com Era

    Author Photo

    Regulatory responses following the dot-com collapse reflected a consistent emphasis on whether public disclosures enabled investors to understand the economic reality underlying reported performance, a focus that is likely to shape how artificial intelligence infrastructure disclosures are evaluated if market expectations similarly deteriorate, say Diana Connor, Adrienna Huffman and Bin Zhou at the Brattle Group.

  • Have Iconic Twitter Trademarks Been Abandoned?

    Author Photo

    A set of lawsuits concerning the status of X Corp.'s "Twitter" and "tweet" trademarks, which will potentially be considered abandoned in July, will provide instructive insights into how trademark owners can defend against abandonment claims, say attorneys at Bradley Arant.

  • Google's Scraping Suit Asks How Far DMCA Protections Go

    Author Photo

    A California federal court's decision in Google v. SerpApi will spotlight a long-developing judicial split over how to apply the Digital Millennium Copyright Act’s ban on circumventing a copyright holder’s access controls, an increasingly important point in litigation over web scraping and artificial intelligence training, say attorneys at Jenner & Block.

  • Series

    Podcasting Makes Me A Better Lawyer

    Author Photo

    Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.

  • Del. Coinbase Outcome May Have Been Different In Texas

    Author Photo

    The Delaware Court of Chancery's recent decision in Grabski v. Andreessen, finding that a member of the Coinbase special litigation committee was not independent, provides guidance for Delaware boards regarding the formation, composition and operation of SLCs, while offering a counterpoint to the procedures available to Texas-incorporated companies, says John Lawrence at Baker Botts.

  • Share Repurchases Leave Cos. Susceptible To Litigation

    Author Photo

    Because share repurchases bring greater ownership, which typically brings greater voting power, they can have serious implications for corporate control, which can raise questions about the unpaid benefits to some shareholders and lead to securities class actions, says Amit Bubna at Bates White.

  • 9th Circ. Ruling Evinces Tightening Of Nonmedical Hardship

    Author Photo

    The Ninth Circuit’s recent ruling in Vilchis-Gomez v. Bondi illustrates how a series of immigration decisions are transforming the extreme hardship defense to removal into a de facto medical necessity requirement, but practitioners can push back by continuing to assert long-standing precedents and building comprehensive records, says Abdoul Konare at Konare Law.

  • Del. Justices' Upholding Of SB 21 Gives Cos. Needed Clarity

    Author Photo

    The Delaware Supreme Court's recent unanimous decision in Rutledge v. Clearway Energy — upholding 2025 corporate law amendments enacted through S.B. 21, which clarified safe harbor protections and key terms — may help stem the DExit movement, whose proponents have claimed unpredictability in Delaware courts, say attorneys at Nelson Mullins.

  • Unique Issues Facing Brand-Compounder Patent Litigation

    Author Photo

    Recent litigation and potential enforcement action against Hims & Hers Health raise questions about how compounders and branded pharmaceuticals companies would be positioned in patent litigation as compared to generics companies, which would require strategies different from those that would be used in traditional Hatch-Waxman Act litigation, say attorneys at Morgan Lewis.

  • Series

    Volunteering With Scouts Makes Me A Better Lawyer

    Author Photo

    Serving as an assistant scoutmaster for my son’s troop reaffirmed several skills and principles crucial to lawyering — from the importance of disconnecting to the value of morality, says Michael Warren at McManis Faulkner.

  • Series

    Law School's Missed Lessons: In Court, It's About Storytelling

    Author Photo

    Law school provides doctrine, cases and hypotheticals, but when lawyers step into the courtroom, they must learn the importance of clarity, credibility, memorability and preparation — in other words, how to tell simple, effective stories, say Nicholas Steverson and Danielle Trujillo at Wheeler Trigg, and Lisa DeCaro at Courtroom Performance.

  • How Recent Del. Rulings Clarify M&A Deal Fraud Carveouts

    Author Photo

    Two recent Delaware decisions have provided clarity regarding when a party can or cannot rely on representations made during the course of an M&A transaction, particularly on the scope and enforceability of antireliance provisions, and on representations they knew or should have known were false, says Anthony Boccamazzo at Olshan Frome.

  • High Court's 'Skinny Label' Case May Tackle Wider Questions

    Author Photo

    The U.S. Supreme Court's upcoming decision in Hikma v. Amarin will have important ramifications for broader debates over what defines a generic version of a drug, and the pending case is already altering patent practice, say attorneys at Taft.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Delaware archive.